Neoplasms, Esophageal Completed Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Neoplasm, Esophageal / Esophageal Neoplasm / Esophageal Neoplasms / Oesophageal neoplasm / Esophageal neoplasm NOS / Oesophageal neoplasm NOS / Tumor of esophagus

IndicationStatusPhase
DBCOND0055130 (Neoplasms, Esophageal)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00390416Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal AdenocarcinomaTreatment
NCT00447330Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric AdenocarcinomaTreatment